Loading...
Optimizing survival outcomes with post‐remission therapy in acute myeloid leukemia
Optimization of post‐remission therapies to maintain complete remission and prevent relapse is a major challenge in treating patients with acute myeloid leukemia (AML). Monitoring patients for measurable residual disease (MRD) is helpful to identify those at risk for relapse. Hypomethylating agents...
Na minha lista:
| Udgivet i: | Am J Hematol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6593671/ https://ncbi.nlm.nih.gov/pubmed/30945331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25484 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|